Shailesh D Siroya

Board approved Q2 FY27 unaudited standalone and consolidated financial results with unmodified auditor review. Standalone Q2 net profit increased to ₹152.71 lakh from ₹78.17 lakh YoY, with revenue up

Bal Pharma reported unaudited Q2 FY27 standalone revenue of ₹897.2 lakhs and net profit of ₹152.71 lakhs, a 95% YoY increase. The company raised ₹210 lakhs through a preferential warrant issue in Sept